Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Therapeutic Targets
List of Issues
Volume 18, Issue 12

Expert Opinion on Therapeutic Targets

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Therapeutic Targets, Volume 18, Issue 12 (2014)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 18, Issue 12 (2014)

See all volumes and issues

Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Volume 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4

Ying Huang, Yuan Qi, Jian-Qing Du & Dai-fu Zhang

Pages: 1355-1365

Published online: 17 Oct 2014

AbstractforMicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4 | Full Text | References | PDF (730.9 KB) | Supplemental

741 Views
40 CrossRef citations
0Altmetric

Article

Hepatotoxicity induced by neonatal exposure to diethylstilbestrol is maintained throughout adulthood via the nuclear receptor SHP

Aurélie Vega, Marine Baptissart, Emmanuelle Martinot, Jean-Paul Saru, Silvère Baron, Kristina Schoonjans & David H Volle

Pages: 1367-1376

Published online: 29 Sep 2014

AbstractforHepatotoxicity induced by neonatal exposure to diethylstilbestrol is maintained throughout adulthood via the nuclear receptor SHP | Full Text | References | PDF (752.7 KB) | Supplemental

205 Views
2 CrossRef citations
0Altmetric

Reviews

Review Article

Aurora kinase A inhibitors: promising agents in antitumoral therapy

Marcos Malumbres PhD & Ignacio Pérez de Castro PhD

Pages: 1377-1393

Published online: 09 Sep 2014

AbstractforAurora kinase A inhibitors: promising agents in antitumoral therapy | Full Text | References | PDF (572.6 KB) | Supplemental

819 Views
2 CrossRef citations
0Altmetric

Review Article

Multi-targeted molecular therapeutic approach in aggressive neuroblastoma: the effect of Focal Adhesion Kinase–Src–Paxillin system

Panagiotis Kratimenos MD, Ioannis Koutroulis, Dante Marconi, Vasiliki Syriopoulou, Maria Delivoria-Papadopoulos, George P Chrousos & Stamatios Theocharis

Pages: 1395-1406

Published online: 05 Sep 2014

AbstractforMulti-targeted molecular therapeutic approach in aggressive neuroblastoma: the effect of Focal Adhesion Kinase–Src–Paxillin system | Full Text | References | PDF (346.4 KB)

393 Views
1 CrossRef citations
0Altmetric

Review Article

The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer

Brian S Henick MD, Roy S Herbst MD PhD & Sarah B Goldberg MD MPH

Pages: 1407-1420

Published online: 21 Oct 2014

AbstractforThe PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer | Full Text | References | PDF (401.5 KB)

953 Views
17 CrossRef citations
0Altmetric

Review Article

The potential for targeting HER2 therapeutically in esophageal cancer – a grasp at straws?

Faik G Uzunoglu MD, Alexandra M Koenig MD & Jakob R Izbicki MD

Pages: 1421-1426

Published online: 26 Sep 2014

AbstractforThe potential for targeting HER2 therapeutically in esophageal cancer – a grasp at straws? | Full Text | References | PDF (185.9 KB)

183 Views
1 CrossRef citations
0Altmetric

Review Article

Antithrombotic therapy: new areas to understand efficacy and bleeding

James W Wisler MD & Richard C Becker MD

Pages: 1427-1434

Published online: 27 Oct 2014

AbstractforAntithrombotic therapy: new areas to understand efficacy and bleeding | Full Text | References | PDF (195.1 KB)

245 Views
2 CrossRef citations
0Altmetric

Review Article

Filamin A interacting protein 1-like as a therapeutic target in cancer

Mijung Kwon PhD & Steven K Libutti MD

Pages: 1435-1447

Published online: 09 Sep 2014

AbstractforFilamin A interacting protein 1-like as a therapeutic target in cancer | Full Text | References | PDF (674.6 KB)

304 Views
0 CrossRef citations
0Altmetric

Review Article

Targeting FXR in cholestasis: hype or hope

Stefano Fiorucci, Eleonora Distrutti, Patrizia Ricci, Vittorio Giuliano, Annibale Donini & Franco Baldelli

Pages: 1449-1459

Published online: 09 Sep 2014

AbstractforTargeting FXR in cholestasis: hype or hope | Full Text | References | PDF (394.2 KB)

804 Views
3 CrossRef citations
0Altmetric

Review Article

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

Shang-Yi A Tsai, Michael J Pokrass, Neal R Klauer, Nicole E De Credico & Tsung-Ping Su

Pages: 1461-1476

Published online: 21 Oct 2014

AbstractforSigma-1 receptor chaperones in neurodegenerative and psychiatric disorders | Full Text | References | PDF (462 KB)

622 Views
23 CrossRef citations
0Altmetric

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Ways of modulating GABA transporters to treat neurological disease

Jonas S. Mortensen et al.

Review Article | Published online: 27 Jul 2024

Open Access

Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes

Mohammad Sadegh Gheibzadeh et al.

Review Article | Published online: 19 Jul 2024

The role of adipokines in the pathogenesis of psoriasis – a focus on resistin, omentin-1 and vaspin

Kajetan Kiełbowski et al.

Review Article | Published online: 5 Jul 2024

Pathways and targeting avenues of BRAF in non-small cell lung cancer

Evgeny N. Imyanitov et al.

Review Article | Published online: 4 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Targets (Vol.18, Iss.12, 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?